Maiwei Biotech (688062.SH): FDA approval obtained for clinical trial application of 9MW1911 injection.

date
23/12/2025
Cnstock Finance APP News, Microway Biotech (688062.SH) announced that the company recently received the "Study May Proceed Notification" issued by the U.S. Food and Drug Administration (FDA). The clinical trial application for 9MW1911 injection has officially been granted FDA approval.